Woods J E, DeSanto L W, Ritts R E
Surg Clin North Am. 1977 Aug;57(4):769-78. doi: 10.1016/s0039-6109(16)41287-9.
In a randomized prospective study of patients with advanced squamous cell carcinoma of the head and neck, treatment with MTX plus BCG and with MTX plus BCG plus INH produced no better response rate or survival time than treatment with MTX alone.
在一项针对晚期头颈部鳞状细胞癌患者的随机前瞻性研究中,与单独使用甲氨蝶呤治疗相比,甲氨蝶呤联合卡介苗以及甲氨蝶呤联合卡介苗加异烟肼治疗的缓解率和生存时间并无改善。